Singular Genomics Systems (OMIC) released new data from 11 industry-leading genomics partners that validate the performance and versatility of the G4 Sequencing Platform. The datasets are being released during the Advances in Genome Biology and Technology, AGBT, 23rd General Meeting taking place February 6-9, 2023, in Hollywood, Florida. The datasets, available as application notes and posters at the AGBT meeting and on the Singular Genomics website, are with the following industry-leading genomics partners: 10x Genomics (TXG), Integrated DNA Technologies, Bio-Rad Laboratories (BIO), QIAGEN (QGEN), Quantabio, Parse Biosciences, Takara Bio, Paragon Genomics, Watchmaker Genomics, Claret Bioscience, and Tecan. "The data with our partners underscores the versatility of the G4 to address our customers’ various sequencing needs, producing highly accurate results with unmatched flexibility and speed," said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OMIC:
- Singular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBT
- Singular Genomics joins 10x Genomics Compatible Partner Program
- Singular Genomics Joins the 10x Genomics Compatible Partner Program
- Singular Genomics sees Q4 revenue about $700,000, consensus $650,000
- Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue